Join to View Full Profile
200 1st St SwRochester, MN 55905
Phone+1 507-284-2511
Dr. Jatoi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Aminah Jatoi is an oncologist based in Rochester, MN, with extensive expertise in pancreatic cancer, gastrointestinal oncology, and general medical oncology. She completed her fellowship in Hematology and Medical Oncology at the University of Minnesota and her residency in Internal Medicine at Case Western Reserve University/University Hospitals Cleveland Medical Center, after graduating from the University of Texas Medical Branch School of Medicine in 1987. Her published works focus on a range of topics, including challenges in cancer cachexia research. Dr. Jatoi is actively involved in clinical trials, such as investigating treatments for loss of appetite in advanced cancer patients and assessing exercise for cancer patients at high fall risk.
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 1990 - 1993
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1987 - 1990
University of Texas Medical Branch School of MedicineClass of 1987
Certifications & Licensure
MN State Medical License 1992 - 2026
TX State Medical License 1988 - 1999
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 2 Certification Mayo Clinic Incorporate Lab Results, Mayo Clinic, 2014-2017
- CMS Meaningful Use Stage Stage 1 Certification Centricity Patient Online, GE Healthcare, 2014-2017
- CMS Meaningful Use Stage Stage 2 Certification Centricity Patient Online, GE Healthcare, 2014-2017
Clinical Trials
- Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach Start of enrollment: 2000 Jan 01
- Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-small Cell Lung Cancer Start of enrollment: 2000 Jan 01
- Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy Start of enrollment: 2000 Dec 01
Publications & Presentations
PubMed
- 1 citationsHomelessness and Cancer: A Multi-Site, Mixed Methods Study of Delayed or No Cancer Therapy.Robert J Haemmerle, Kelliann Fee-Schroeder, Lynn Phelan, Aminah Jatoi, Elizabeth Cathcart-Rake
The American Journal of Hospice & Palliative Care. 2026-02-01 - Was It Worth It? Response Data from >650 US and International Participants in Chemoprevention Trials.David Zahrieh, Carrie A Strand, Paul J Limburg, Aminah Jatoi, Sumithra J Mandrekar
Cancer Prevention Research. 2026-01-06 - Navigating Between Scylla and Charybdis: Cancer, Lorlatinib, and Neurocognitive Adverse Events.Ryan Brown, Mohamed M Shanshal, Aminah Jatoi
Mayo Clinic Proceedings. 2025-12-30
Journal Articles
- Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast CancerAminah Jatoi, Antonio C Wolff, Harvey Jay Cohen, Rachel A Freedman, Gustav Magrinat, Julie Gralow, Gretchen Kimmick, Heidi D Klepin, Harold Burstein, Hyman Muss, Jeann..., Journal of the American Geriatrics Society
Abstracts/Posters
- Alliance A041702: A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (_ 70 Years...Aminah Jatoi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Alliance A041702: A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (_ 70 Years...Aminah Jatoi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Optimizing Management of Colorectal Cancer in Older AdultsASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
- Preemptive versus reactive topical clobetasol for regorafenib-induced hand-foot reactions: Results from the ReDOS trial.2019 ASCO Annual Meeting - 6/1/2019
- Expanding the Scope of Precision Medicine: Integration of Patient Preference and Experience. Personalizing Care for Older Adults With Cancer: From Decision-Making to C...2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Other
- What Occurs in the Other 20% of Cancer Patients with Chemotherapy-Induced Nausea and Vomiting (CINV)? A Single-Institution Qualitative StudyAminah Jatoi, MD, Supportive care in cancer
https://www.doximity.com/articles/00544396-d46d-4d22-b73b-618d01365161
UpToDate, Wolters Kluwer Health - 2012-06-08
Press Mentions
The Overlooked (And Weird) Symptom Many with Cancer HaveDecember 5th, 2022- Hiccups in Patients with Cancer Often Overlooked, UndertreatedNovember 16th, 2022
- Hiccups in Patients with Cancer Often Overlooked, UndertreatedNovember 16th, 2022
Grant Support
- Older Sexual Minority Patients with Serious Illness: Program-Building to Identify and Address NeedsMAYO CLINIC ROCHESTER2022–2027
- Paul Calabresi Program in Clinical/Translational Research at Mayo ClinicMAYO CLINIC ROCHESTER2001–2026
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
